期刊論文| 1. | Cleeland, C. S.(1984)。The impact of pain on the patients with cancer。Cancer，54，2635-2641。   |
| 2. | Jill, A. R.(1996)。Care of the terminal ill patient : barriers to effective palliative care of terminal patients。Clinics in Geriatric Medicine，407-416。 |
| 3. | Joranson, D. E.(1993)。Availability of opioids for cancer : Recent trends, assessment of system barriers, new WHO guidelines and the risk of diversion。J. Pain Sympt Management，8，353-360。 |
| 4. | Porter, J.、Jick, H.(1980)。Addiction rare in patient treated with narcotics。N Engl J Med，302，123。 |
| 5. | Inturrisi, C. E.(1989)。Management of cancer pain : pharmacology and principles of management。Cancer，63，2308-2320。 |
| 6. | Lipman, A. G.、Gauthier, M. E.(1997)。Pharmacology of Opioid Drugs: Basic Principles。Topics in Palliative Care，1，137-161。 |
| 7. | Nathan, I. C.、Kathleen, M. F.(1996)。Nonopioid and opioid analgesic pharmaco-therapy of cancer pain。Hematology/Oncology Clinics of North America，10(1)，79-102。 |
| 8. | Kathleen, M. F.(1985)。The treatment of cancer pain。N Engl J Med，313，84-95。 |
| 9. | Aherne, G. W.、Evelyn, M. P.、Twycross, G.(1979)。Serum morphine concentration after oral administration of diamorphine hydrochloride and morphine sulphate。Br. J. clin. Pharmac.，8，577-580。 |
| 10. | Christrup(1997)。Morphine metabolites。Acta Anetheaol Scand，41，116-122。 |
| 11. | Davies, G.、Kingswood, C.、Street, M.(1996)。Pharmacokinetics of Opioid in renal dysfunction。Clinical Pharmacokinetics，31，410-432。 |
| 12. | Ashby, M.、Fleming, B.、Wood, M.、Somogy, A.(1997)。Plasma morphine and glucuronide (M3G and M6G) concentration in hospice inpatients。J Pains & Symptom Management，14，157-167。 |
| 13. | Hanks, G. W.(1991)。Morphine pharmacokinetics and analgesia after oral administration。Postgrad Med J，67(Suppl.2)，S60-S63。 |
| 14. | Milne, R. W.、Nation, R. L.(1991)。High-performance liquid chromatographic determination of morphine and its 3- and 6-glucuronide metabolites : improvements to the method and application to stability studies。J chromatography，565，457-464。 |
| 15. | Clara, C. F.、Sally, L. C.、Moore、Henry, J. M.(1998)。Systematic review of factors affecting the ratios of morphine and its major metabolites。Pain，74，43-53。 |
| 16. | McQuay, Henry J.、Carroll, Dawn、Faura, Clara C.、Gavaghan, David J.、Hand, Christopher W.、Moore, R. Andrew(1990)。Oral morphine in cancer pain: Influences on morphine and metabolite concentration。Clin Pharmacol Ther，48，236-244。 |
| 17. | Mercadante, S(1999)。The role of morphine glucuronides in cancer pain。Palliat Med，13，95-104。 |
| 18. | Parkinson, S. K.、Bailey, S. L.、Little, W. L.、Mueller, J. B.(1990)。Myoclonic seizure activity with chronic high-dose spinal opioid administration。Anesthesiology，72，743-745。 |
| 19. | Sjogren, P.、Jonsson, T.、Jensen, N.-H.、Drenck, N.-E.、Jensen, T. S.(1993)。Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine。Pain，55，93-97。 |
| 20. | Sjogren, P.、Dragsted, L.、Christensen, C. B.(1993)。Myoclonic spasms during treatment with high doses of intravenous morphine in renal failure。Acta Anaesthesiol Scand，37，780-782。 |
| 21. | Goucke, C. R.、Hackett, L. P.、Ilett, Kenneth F.(1994)。Concentrations of morphine, morphine-6- glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain。Pain，56，145-149。 |
| 22. | Osborne, R.、Joel, S.、Trew, D.(1990)。Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite M6G。Clin Pharmacol Ther，47，12-19。 |
| 23. | Laizure, S. C.、Miller, J. H.、Stevens, R. C.(1993)。The dispositon and cerebrospinal fluid penetration of morphine and its two major glucuronidated metabolites in adults undergoing lumbar myelography。Pharmacotherapy，13，471-475。 |
| 24. | Laizure, S. C.(1994)。Considerations in morphine therapy。Am J Hosp Pharm，51，2042-2043。 |
| 25. | Kathleen, M. F.(1999)。Advances in cancer pain。Arch Neurol，56，413-417。 |
| 26. | Bentley, J. B.、Borel, J. D.、Gillespie, T. J.(1981)。Fentanyl biotransformation in obese and nonobese patients。Anesthesiology，55，A177。 |
| 27. | Mather, L. E.(1983)。Pharmacokinetic and pharmacodynamic factors influencing the choice, dose and route of administration of opiates for acute pain。Chin Anesthesiology，1，17-40。 |
| 28. | Ventafridda, V.、Ripamonti, C.、De Conne, F.、Bianchi, M.、Pazzuconi, F.、Panerai, A. E.(1987)。Antidepressants increase bioavailability of morphine in cancer patients。Lancet，1，1204。 |
| 29. | Pacifici, G. M.、Rane, A.(1981)。Inhibition of morphine glucuronidation by oxazepam in human fetal liver microsomes。Drug Metab Disp，9，569-572。 |
| 30. | 姚建安、邱泰源、陳慶餘(20010900)。臨床使用嗎啡控制癌末疼痛之研究。臺灣家庭醫學雜誌，11(3)，139-145。 延伸查詢 |
| 31. | 邱泰源(19970300)。癌症末期疼痛的控制。臺灣醫學，1(2)，198-208。 延伸查詢 |
| 32. | 陳民虹、邱泰源、胡文郁、陳慶餘(19970300)。癌末病人疼痛控制之研究。中華民國家庭醫學雜誌，7(1)，24-32。 延伸查詢 |